Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a 2‐part study, with Part A being the randomized, controlled portion of the study in patients with ABC hospital‐acquired bacterial pneumonia (HABP), ventilator‐associated bacterial pneumonia (VABP), or bacteremia. Part B is the single‐group portion of the study and includes ABC infections that are resistant to or have failed colistin or polymyxin B treatment, as detailed in the inclusion criteria.
Epistemonikos ID: e6df2257260694b7e32ba34144222ce4ea5a5fc0
First added on: May 22, 2024